| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/30/1996 | US5541293 Consensus human leukocyte interferon |
| 07/30/1996 | US5541288 Peptide having elastase inhibitory activity and producing method thereof |
| 07/30/1996 | US5541221 Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss |
| 07/30/1996 | US5541219 Antiinflammatory agents; aids |
| 07/30/1996 | US5541210 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 andrenoceptor agonists |
| 07/30/1996 | US5541208 Potassium channel antagonist, alzheimer*s disease and cognition activators |
| 07/30/1996 | US5541204 Aryloxypropanolamine β 3 adrenergic agonists |
| 07/30/1996 | US5541195 1-acylpiperidine compounds |
| 07/30/1996 | US5541190 Treating benign prostatic hyperplasia, male pattern baldness, prostatic cancer, androgenic alopecia |
| 07/30/1996 | US5541184 S-timolol hemihydrate treatment process |
| 07/30/1996 | US5541183 Ginkgolide derivatives |
| 07/30/1996 | US5541168 Proteolytic enzyme inhibitors; degenerative diseases; respiratory, skin, genetic and gastrointestinal disorders; antiarrthritic and -inflammatory agents; genetic diseases |
| 07/30/1996 | US5541163 Renin inhibiting N-(2-amino-2-oxoethyl)butanediamide derivatives |
| 07/30/1996 | US5541159 Calcitonin derivatives |
| 07/30/1996 | US5541111 Lactobacillus helveticus mutants having low increase in acidity of lactic acid during storage |
| 07/30/1996 | US5540926 Gp39 protein |
| 07/30/1996 | US5540923 Antiviral, antitumor, from trophoblast cells |
| 07/30/1996 | CA1338500C Glycosylated amino acids and peptides |
| 07/30/1996 | CA1338489C Pharmaceutical preparation containing 2,6-diamino-3-phenyl-azo-pyridine |
| 07/27/1996 | CA2141126A1 Combinational drug for treating migraine and other illnesses |
| 07/26/1996 | CA2167979A1 Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders |
| 07/25/1996 | WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/25/1996 | WO1996022368A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022290A1 Compounds having effects on serotonin-related systems |
| 07/25/1996 | WO1996022287A1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 07/25/1996 | WO1996022282A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | WO1996022279A1 New derivatives of glycylanilides, preparation and therapeutical application |
| 07/25/1996 | WO1996022278A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
| 07/25/1996 | WO1996022068A2 Methods and pharmaceutical compositions employing desmethylselegiline |
| 07/25/1996 | WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | CA2211786A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
| 07/25/1996 | CA2211342A1 New derivatives of glycylanilides, preparation and therapeutical application |
| 07/25/1996 | CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | CA2210688A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | CA2210618A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | CA2210220A1 Compounds having effects on serotonin-related systems |
| 07/24/1996 | EP0723146A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722951A2 Method and apparatus for the production of TGF-beta and purified TGF-beta compositions |
| 07/24/1996 | EP0722944A1 2-9-Disubstituted Purin-6-ones |
| 07/24/1996 | EP0722943A1 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/24/1996 | EP0722942A1 Indole piperidine derivatives |
| 07/24/1996 | EP0722941A2 Compounds having effects on serotonin-related systems |
| 07/24/1996 | EP0722937A1 2,8-Disubstituted quinazolinone |
| 07/24/1996 | EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof |
| 07/24/1996 | EP0722726A1 Benzofuran derivatives for inhibiting bone loss |
| 07/24/1996 | EP0722724A1 Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressants |
| 07/24/1996 | EP0722715A1 Cosmetic compositions containing lactate dehydrogenase inhibitors |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722460A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 07/24/1996 | EP0722459A1 Hemoregulatory penta- or hexapeptides |
| 07/24/1996 | EP0722442A1 Polyazacycloalkanes as dichelants |
| 07/24/1996 | EP0722440A1 Pyrimidinyl-glutamic acid derivatives |
| 07/24/1996 | EP0722439A1 Hiv protease inhibitors |
| 07/24/1996 | EP0722431A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 07/24/1996 | EP0722334A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
| 07/24/1996 | EP0722324A1 Pharmaceutical composition for immunoenhancement therapy |
| 07/24/1996 | EP0722322A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 07/24/1996 | EP0722312A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 07/24/1996 | CN1127529A Agonists and antagonists of human interleukin-10 |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127258A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127257A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127256A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127253A Synthesis of 3-(4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes 08/01/31 |
| 07/24/1996 | CN1127252A Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 07/24/1996 | CA2167763A1 Mercaptoalkyldipeptide derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/23/1996 | US5539128 Compounds for inhibiting leukotriene receptors as antiasmatics, antiarthritics, skin disorders, antiulcer agents or cardiovascular disorders |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5539000 Spray-chilled nabumetone |
| 07/23/1996 | US5538997 2,4-diamino-3-hydroxycarboxylic acid derivatives |
| 07/23/1996 | US5538986 Tricyclic derivatives, compositions and methods of use |
| 07/23/1996 | US5538982 Medical use for tachykinin antagonists |
| 07/23/1996 | US5538981 5-hydroxytryptamine receptor antagonist activity |
| 07/23/1996 | US5538980 Central nervous system |
| 07/23/1996 | US5538968 Alzheimer's disease |
| 07/23/1996 | US5538949 Angiogenesis inhibitors |
| 07/23/1996 | US5538945 Stimulation of hair growth by peptide copper complexes |
| 07/23/1996 | US5538731 Plant extract from solvent extraction as enzyme inhibitors for skin depigmentation |
| 07/23/1996 | US5538722 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 07/23/1996 | CA1338484C 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 07/23/1996 | CA1338474C Pyridoindole derivatives and processes for preparation thereof |
| 07/21/1996 | CA2167469A1 Methods of inhibiting bone loss |
| 07/21/1996 | CA2167456A1 Use of l-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-a and other immunodeppresant drugs |
| 07/20/1996 | CA2167353A1 2,9-disubstituted purin-6-ones |
| 07/20/1996 | CA2167349A1 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/20/1996 | CA2167345A1 2,8-disubstituted quinazolinones |
| 07/18/1996 | WO1996021736A1 Human geranylgeranyl pyrophosphate synthetase |
| 07/18/1996 | WO1996021732A1 Il-2r-associated polypeptide and dna molecules coding therefor |
| 07/18/1996 | WO1996021724A1 Human deoxycytidine kinase 2 |
| 07/18/1996 | WO1996021667A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| 07/18/1996 | WO1996021661A1 Piperidine derivatives having tachykinin antagonist activity |
| 07/18/1996 | WO1996021655A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021468A2 Chemically modified interferon |
| 07/18/1996 | WO1996021456A1 Inhibitors of prenyl transferases |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |